Roche wins emergency approval from FDA for antibody test to determine if people have ever been infected with the coronavirus.

  • Company will try to double production of tests from about 50 million/mo to more than 100 million/mo by end of year.
  • “Governments, businesses and individuals are seeking such blood tests to learn who may have had the disease, who may have some immunity and to potentially craft strategies to help end national lockdowns.”
  • Roche also makes tests that identify active COVID-19 infections with a specificity rate of >99.8%.